Fear Shakes Up Intuitive Surgical's Stock

Shares of medical robotics maker Intuitive Surgical (NASDAQ: ISRG  ) are in free-fall today after yesterday's earnings, with the stock plummeting 4.7% after losing a bundle yesterday as well. Earnings aren't the disappointment, however: Intuitive destroyed analyst expectations and showed solid growth in both procedures and device sales. Investors haven't been so kind to the stock, however, and with shares of the company down almost 8% in the last five days alone, it's time to ask: Why is everyone selling this stock?

Investors in a panic attack
The company's financial footing certainly isn't the culprit. Intuitive drilled earnings-per-share expectations, topping projections by $0.58 and beating revenue estimates by almost $30 million. The firm also racked up double-digit growth in both categories over the quarter a year ago, including growth of more than 30% in EPS.

So, what's really behind Intuitive's fall? It's fear.

The company has been in the spotlight recently with concerns mounting about the safety of robotic surgery. Shares weren't helped when the Food and Drug Administration announced it would investigate the company's da Vinci surgical device's complaints, looking to evaluate if the costly machine (da Vinci devices cost around $1.5 million each) added any value over traditional surgeries. That was enough to spark fear among investors, who have panicked over the thought that robotic surgery could come under fire by safety regulators. The FDA's investigation isn't an indictment, however; it's simply a follow-up on complaints.

Yet when we examine the claims more closely, it's too early to pin the blame of surgical complaints on Intuitive. The company went to trial recently over the first of several lawsuits over the da Vinci, and details are emerging that Intuitive has warned physicians about the type of patients operated on with the device. Intuitive also recommends the device for sufficiently skilled surgeons, and while at least one witness has argued that the company targeted surgeons with limited skills, for now it seems just as likely that physician failure, rather than the device itself, is responsible for da Vinci injuries.

Furthermore, the number of injuries and deaths attributable to the da Vinci is minute compared to how many operations the devices have performed. The system performed more than 300,000 operations last year alone and around 1.5 million since 2000. While justifying deaths on an operating table is never acceptable, fatalities happen in robot-assisted and traditional surgeries alike due to complications and over adverse effects.

Overall, investor fear over the da Vinci's negative PR shouldn't outweigh what this company's done in terms of growth. Between growing procedures at a steady clip (Intuitive saw 18% procedural growth last quarter despite the negative spotlight) and increasing both its top and bottom lines, Intuitive's performed as well as any major company in the health care field recently. Don't let fear drag down your investment: Intuitive's dip is a great opportunity to buy into a standout company for less.

Are stories of Intuitive's demise greatly exaggerated?
Recently, some investors have questioned Intuitive Surgical's future. However, Intuitive Surgical expert Karl Thiel believes a visible path to long-term growth persists. Will Intuitive capitalize, or be crushed by unforeseen pitfalls? His report highlights all of the key opportunities and risks facing the company -- and includes a full year of ongoing updates as key new hits -- so be sure to claim your copy by clicking here now.


Read/Post Comments (1) | Recommend This Article (3)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On April 19, 2013, at 3:57 PM, NeedaClue7 wrote:

    Agree completely. The main point to consider is not whether there have been injuries & deaths in robotic assisted surgery, but rather the question of incidence rates compared to traditional surgery. With every surgical procedure, using any technique, there are unexpected outcomes.

    Another point I saw from someone claiming to be an anesthesiologist is that much of the "concern" in the medical community with robotic surgery is from older surgeons that can't or won't adapt. It will be interesting to see how it plays out

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2374138, ~/Articles/ArticleHandler.aspx, 8/29/2014 4:07:21 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement